These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 26845235)
1. Fragment Screening of Soluble Epoxide Hydrolase for Lead Generation-Structure-Based Hit Evaluation and Chemistry Exploration. Xue Y; Olsson T; Johansson CA; Öster L; Beisel HG; Rohman M; Karis D; Bäckström S ChemMedChem; 2016 Mar; 11(5):497-508. PubMed ID: 26845235 [TBL] [Abstract][Full Text] [Related]
3. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography. Amano Y; Yamaguchi T; Tanabe E Bioorg Med Chem; 2014 Apr; 22(8):2427-34. PubMed ID: 24656800 [TBL] [Abstract][Full Text] [Related]
4. Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening. Amano Y; Tanabe E; Yamaguchi T Bioorg Med Chem; 2015 May; 23(10):2310-7. PubMed ID: 25862210 [TBL] [Abstract][Full Text] [Related]
5. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening. Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953 [TBL] [Abstract][Full Text] [Related]
6. Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase. Klingler FM; Wolf M; Wittmann S; Gribbon P; Proschak E J Biomol Screen; 2016 Aug; 21(7):689-94. PubMed ID: 27009944 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA. Karami L; Saboury AA; Rezaee E; Tabatabai SA Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588 [TBL] [Abstract][Full Text] [Related]
8. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors. Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114 [TBL] [Abstract][Full Text] [Related]
9. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659 [TBL] [Abstract][Full Text] [Related]
18. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase. Chen H; Zhang Y; Ye C; Feng TT; Han JG J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795 [TBL] [Abstract][Full Text] [Related]
19. Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors. Anandan SK; Do ZN; Webb HK; Patel DV; Gless RD Bioorg Med Chem Lett; 2009 Feb; 19(4):1066-70. PubMed ID: 19168352 [TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach. Jo AR; Kim JH; Yan XT; Yang SY; Kim YH J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]